|
|
||||||||
IMAGING |
Nuclear Medicine Center and Department of Dermatology, Clinical Hospital of the University of Uruguay, Montevideo; and National Institute of Oncology, Montevideo, Uruguay
Previous reports have shown that 99mTc-sestamibi (MIBI) could detect clinically occult metastatic melanoma lesions. This article reports on a patient with invasive melanoma of the right heel in whom the sentinel node status was preoperatively evaluated with this tracer. Although regional lymph nodes were clinically negative, 99mTc-MIBI scintigraphy showed focal increased tracer uptake in the right groin that corresponded to the location of 2 sentinel nodes visualized by lymphoscintigraphy with 99mTc-colloidal rhenium sulfide performed the same day. A
-probe was used intraoperatively to guide the excision of the sentinel nodes that were further classified as metastatic by histopathology. This double-technique approach is technically feasible and has the potential of selecting a group of patients who might benefit from a selective complete lymphadenectomy.
Key Words: lymphoscintigraphy; melanoma; sentinel lymph nodes; 99mTc-MIBI
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE JOURNAL OF NUCLEAR MEDICINE | JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY |